Bellevue Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $83M | Buy |
957,329
+190,737
| +25% | +$18.3M | 1.97% | 18 |
|
|
2025
Q4 | $73.6M | Buy |
766,592
+6,731
| +0.9% | +$654K | 1.4% | 21 |
|
|
2025
Q3 | $72.4M | Sell |
759,861
-161,182
| -17% | -$14.8M | 1.5% | 18 |
|
|
2025
Q2 | $80.3M | Sell |
921,043
-17,312
| -2% | -$1.47M | 1.77% | 15 |
|
|
2025
Q1 | $84.3M | Sell |
938,355
-104,593
| -10% | -$9.36M | 1.89% | 14 |
|
|
2024
Q4 | $83.3M | Buy |
1,042,948
+34,315
| +3% | +$2.97M | 1.6% | 16 |
|
|
2024
Q3 | $90.8M | Buy |
1,008,633
+6,886
| +0.7% | +$579K | 1.47% | 21 |
|
|
2024
Q2 | $78.8M | Sell |
1,001,747
-5,253
| -0.5% | -$431K | 1.28% | 21 |
|
|
2024
Q1 | $87.8M | Buy |
1,007,000
+36,228
| +4% | +$3.09M | 1.34% | 21 |
|
|
2023
Q4 | $80M | Buy |
970,772
+329,280
| +51% | +$25.1M | 1.22% | 21 |
|
|
2023
Q3 | $50.3M | Sell |
641,492
-769,000
| -55% | -$64.4M | 0.81% | 34 |
|
|
2023
Q2 | $124M | Buy |
1,410,492
+181,257
| +15% | +$15.6M | 1.77% | 15 |
|
|
2023
Q1 | $99.1M | Buy |
1,229,235
+610,815
| +99% | +$49.8M | 1.44% | 17 |
|
|
2022
Q4 | $48.1M | Buy |
618,420
+2,494
| +0.4% | +$202K | 0.64% | 52 |
|
|
2022
Q3 | $49.7M | Sell |
615,926
-29,580
| -5% | -$2.66M | 0.71% | 45 |
|
|
2022
Q2 | $57.9M | Sell |
645,506
-10,524
| -2% | -$1.07M | 0.82% | 40 |
|
|
2022
Q1 | $72.8M | Sell |
656,030
-11,378
| -2% | -$1.2M | 0.85% | 43 |
|
|
2021
Q4 | $69M | Buy |
667,408
+328,283
| +97% | +$38M | 0.71% | 49 |
|
|
2021
Q3 | $42.5M | Sell |
339,125
-20,500
| -6% | -$2.65M | 0.43% | 72 |
|
|
2021
Q2 | $44.6M | Buy |
359,625
+27,103
| +8% | +$3.4M | 0.44% | 72 |
|
|
2021
Q1 | $39.3M | Sell |
332,522
-128,736
| -28% | -$15.1M | 0.42% | 81 |
|
|
2020
Q4 | $54M | Sell |
461,258
-370,192
| -45% | -$40.8M | 0.62% | 50 |
|
|
2020
Q3 | $86.4M | Sell |
831,450
-146,073
| -15% | -$14.7M | 1.19% | 24 |
|
|
2020
Q2 | $89.6M | Buy |
977,523
+32,207
| +3% | +$3.09M | 1.27% | 21 |
|
|
2020
Q1 | $85.2M | Buy |
945,316
+96,986
| +11% | +$10.3M | 1.65% | 15 |
|
|
2019
Q4 | $96.2M | Buy |
848,330
+40,692
| +5% | +$4.47M | 1.53% | 17 |
|
|
2019
Q3 | $87.7M | Buy |
807,638
+28,227
| +4% | +$2.95M | 1.63% | 16 |
|
|
2019
Q2 | $75.9M | Buy |
779,411
+288,505
| +59% | +$26.3M | 1.3% | 22 |
|
|
2019
Q1 | $44.7M | Sell |
490,906
-5,540
| -1% | -$496K | 2.46% | 8 |
|
|
2018
Q4 | $45.2M | Hold |
496,446
| – | – | 2.97% | 8 |
|
|
2018
Q3 | $48.8M | Buy |
496,446
+94,565
| +24% | +$8.74M | 3.1% | 8 |
|
|
2018
Q2 | $34.4M | Buy |
401,881
+44,881
| +13% | +$3.75M | 2.93% | 7 |
|
|
2018
Q1 | $28.6M | Buy |
357,000
+140,000
| +65% | +$11.5M | 2.84% | 8 |
|
|
2017
Q4 | $17.5M | Hold |
217,000
| – | – | 1.83% | 16 |
|
|
2017
Q3 | $16.9M | Sell |
217,000
-88,500
| -29% | -$7.35M | 1.77% | 16 |
|
|
2017
Q2 | $27.1M | Buy |
305,500
+63,000
| +26% | +$5.31M | 3.21% | 3 |
|
|
2017
Q1 | $19.5M | Sell |
242,500
-17,000
| -7% | -$1.33M | 2.6% | 7 |
|
|
2016
Q4 | $18.5M | Buy |
259,500
+12,000
| +5% | +$943K | 3.79% | 3 |
|
|
2016
Q3 | $21.4M | Sell |
247,500
-35,000
| -12% | -$3.05M | 3.86% | 1 |
|
|
2016
Q2 | $24.5M | Buy |
282,500
+6,000
| +2% | +$485K | 4.61% | 1 |
|
|
2016
Q1 | $20.7M | Buy |
+276,500
| New | +$20.8M | 3.76% | 3 |
|
Other funds holding MDT
VCM
VPM
Bellevue Group's MDT Position: Q1 2026 in Review
Bellevue Group increased its Medtronic (MDT) stake by 25% in Q1 2026, buying an estimated $18.3M and bringing the position to 957,329 shares worth $83M. The position accounts for 1.97% of the portfolio, ranked #18.
Bellevue Group first reported a position in MDT in Q1 2016 and has held it in 41 quarters since. The position peaked at $124M in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Bellevue Group held 957,329 shares of Medtronic worth $83M as of Q1 2026.
- Bellevue Group bought 190,737 Medtronic shares in Q1 2026, an estimated $18.3M.
- Medtronic made up 1.97% of Bellevue Group's portfolio in Q1 2026, its #18 holding.
- Bellevue Group first reported a position in Medtronic in Q1 2016 and has held it in 41 quarters since.
- Bellevue Group's Medtronic position peaked at $124M in Q2 2023.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.